A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.
Epistemonikos ID: 6bacffcbd550b86c7d4438654139d4ca543c56ce
First added on: May 22, 2024